Clinical Practice Guideline: Bell's Palsy

Otolaryngology - Head and Neck Surgery - Tập 149 Số S3 - 2013
Reginald F. Baugh1, Gregory J. Basura2, Lisa E. Ishii3, Seth Schwartz4, Caitlin Drumheller5, Rebecca Burkholder6, Nathan A. Deckard7, Cindy Dawson8, Colin L. W. Driscoll9, M. Boyd Gillespie10, Richard K. Gurgel11, John Halperin12, Ayesha N. Khalid13,14, Kaparaboyna Ashok Kumar15, Alan G. Micco16, Debra Munsell17, Steven Rosenbaum18, William Vaughan19
1University of Toledo Medical Center, Toledo, Ohio, USA
2University of Michigan, Ann Arbor, Michigan USA
3Johns Hopkins University, Baltimore, Maryland, USA
4Virginia Mason Medical Center, Seattle, Washington, USA
5Department of Research and Quality Improvement, American Academy of Otolaryngology-Head and Neck Surgery Foundation, Alexandria, Virginia, USA.
6National Consumers League, Washington, DC, USA
7Cooper University, Camden, New Jersey, USA
8University of Iowa, Iowa City, Iowa, USA
9Mayo Clinic Rochester, Minnesota USA
10Medical University of South Carolina, Charleston, South Carolina USA
11University of Utah Salt Lake City, Utah USA
12Overlook Medical Center, Summit, New Jersey, USA
13Emerson Hospital, Concord, Massachusetts, USA
14Harvard Medical School Boston Massachusetts USA
15University of Texas Health Science Center San Antonio, Texas USA
16Northwestern University Feinberg School of Medicine, Chicago, Illinois USA
17Louisiana State University Health Sciences Center New Orleans, New Orleans, Louisiana, USA
18HackensackUMC Mountainside Hospital, Montclair, NJ
19National Committee to Preserve Social Security and Medicare, Falls Church, Virginia, USA

Tóm tắt

Objective

Bell's palsy, named after the Scottish anatomist, Sir Charles Bell, is the most common acute mono‐neuropathy, or disorder affecting a single nerve, and is the most common diagnosis associated with facial nerve weakness/paralysis. Bell's palsy is a rapid unilateral facial nerve paresis (weakness) or paralysis (complete loss of movement) of unknown cause. The condition leads to the partial or complete inability to voluntarily move facial muscles on the affected side of the face. Although typically self‐limited, the facial paresis/paralysis that occurs in Bell's palsy may cause significant temporary oral incompetence and an inability to close the eyelid, leading to potential eye injury. Additional long‐term poor outcomes do occur and can be devastating to the patient. Treatments are generally designed to improve facial function and facilitate recovery. There are myriad treatment options for Bell's palsy, and some controversy exists regarding the effectiveness of several of these options, and there are consequent variations in care. In addition, numerous diagnostic tests available are used in the evaluation of patients with Bell's palsy. Many of these tests are of questionable benefit in Bell's palsy. Furthermore, while patients with Bell's palsy enter the health care system with facial paresis/paralysis as a primary complaint, not all patients with facial paresis/paralysis have Bell's palsy. It is a concern that patients with alternative underlying etiologies may be misdiagnosed or have unnecessary delay in diagnosis. All of these quality concerns provide an important opportunity for improvement in the diagnosis and management of patients with Bell's palsy.

Purpose

The primary purpose of this guideline is to improve the accuracy of diagnosis for Bell's palsy, to improve the quality of care and outcomes for patients with Bell's palsy, and to decrease harmful variations in the evaluation and management of Bell's palsy. This guideline addresses these needs by encouraging accurate and efficient diagnosis and treatment and, when applicable, facilitating patient follow‐up to address the management of long‐term sequelae or evaluation of new or worsening symptoms not indicative of Bell's palsy. The guideline is intended for all clinicians in any setting who are likely to diagnose and manage patients with Bell's palsy. The target population is inclusive of both adults and children presenting with Bell's palsy.

Action Statements

The development group made a strong recommendation that (a) clinicians should assess the patient using history and physical examination to exclude identifiable causes of facial paresis or paralysis in patients presenting with acute‐onset unilateral facial paresis or paralysis, (b) clinicians should prescribe oral steroids within 72 hours of symptom onset for Bell's palsy patients 16 years and older, (c) clinicians should not prescribe oral antiviral therapy alone for patients with new‐onset Bell's palsy, and (d) clinicians should implement eye protection for Bell's palsy patients with impaired eye closure. The panel made recommendations that (a) clinicians should not obtain routine laboratory testing in patients with new‐onset Bell's palsy, (b) clinicians should not routinely perform diagnostic imaging for patients with new‐onset Bell's palsy, (c) clinicians should not perform electrodiagnostic testing in Bell's palsy patients with incomplete facial paralysis, and (d) clinicians should reassess or refer to a facial nerve specialist those Bell's palsy patients with (1) new or worsening neurologic findings at any point, (2) ocular symptoms developing at any point, or (3) incomplete facial recovery 3 months after initial symptom onset. The development group provided the following options: (a) clinicians may offer oral antiviral therapy in addition to oral steroids within 72 hours of symptom onset for patients with Bell's palsy, and (b) clinicians may offer electrodiagnostic testing to Bell's palsy patients with complete facial paralysis. The development group offered the following no recommendations: (a) no recommendation can be made regarding surgical decompression for patients with Bell's palsy, (b) no recommendation can be made regarding the effect of acupuncture in patients with Bell's palsy, and (c) no recommendation can be made regarding the effect of physical therapy in patients with Bell's palsy.

Từ khóa


Tài liệu tham khảo

10.1080/000164802760370736

Lockhart P, 2009, Antiviral treatment for Bell's palsy (idiopathic facial paralysis), Cochrane Database Syst Rev, CD001869

Salinas RA, 2010, Corticosteroids for Bell's palsy (idiopathic facial paralysis), Cochrane Database Syst Rev, CD001942

10.1097/MAO.0b013e3181cabd90

10.1001/archotol.1981.00790370003001

10.2337/diabetes.24.5.449

10.1001/jama.1975.03260060037015

10.1097/00005537-199908000-00001

10.1136/bmj.330.7504.1374

10.3949/ccjm.72.5.398

10.1080/00016480801901659

10.1097/00129492-200101000-00019

10.1056/NEJMcp041120

10.1097/MAO.0b013e3181656998

10.1016/j.mehy.2008.09.023

10.1016/S0163-4453(95)92769-7

10.1097/00002060-200301000-00005

10.1002/lary.1978.88.5.787

10.1080/00016489850182440

10.1177/019459988509300202

10.3109/00016489209136829

10.1097/MAO.0b013e3181ab31c8

10.1016/S1474-4422(08)70221-7

10.1016/S0140-6736(71)92041-1

10.1097/00006527-200410000-00003

10.1007/s004150200038

10.1056/NEJMoa072006

10.1111/j.1442-9071.1990.tb01823.x

Hayashi A, 2005, Use of a suture anchor for correction of ectropion in facial paralysis, Plast Reconstr Surg, 115, 234, 10.1097/01.PRS.0000145719.34091.64

10.1017/S0022215110001507

10.1159/000110333

10.1002/ana.410200511

Monini S, 2010, Epidemiology of Bell's palsy in an Italian Health District: incidence and case‐control study, Acta Otorhinolaryngol Ital, 30, 198

10.1046/j.1468-1331.2002.00343.x

Tsai HS, 2009, Epidemiology and treatment of Bell's palsy in children in northern Taiwan, J Microbiol Immunol Infect, 42, 351

10.1111/j.1440-1754.2007.01245.x

10.1159/000338303

10.1002/lary.21860

10.1159/000151701

10.1097/01.moo.0000134829.61048.64

10.1002/lary.22481

10.1177/0194599812467004

10.7326/0003-4819-139-6-200309160-00013

10.1186/1472-6947-5-23

10.1542/peds.2004-1260

Centre for Evidence Based Medicine.The Oxford 2011 Levels of Evidence.2001.http://www.cebm.net/index.aspx?o=5653

10.1001/jama.287.5.612

10.1503/cmaj.061181

10.1177/00034894880976S301

Tiemstra JD, 2007, Bell's palsy: diagnosis and management, Am Fam Physician, 76, 997

May M, 2000, The Facial Nerve

10.1212/WNL.42.7.1268

Centers for Disease Control and Prevention.Lyme disease data.2012.http://www.cdc.gov/lyme/stats/index.html. Accessed March 27 2013.

Holland J, 2008, Bell's palsy, Clin Evid (Online), 2008, 1204

10.1053/crad.2001.0730

10.1097/TA.0b013e318265cb95

10.1053/crad.2001.0849

10.1148/radiol.12121137

American College of Radiology.ACR statement on recent studies regarding CT scans and increased cancer risk.http://gm.acr.org/MainMenuCategories/media_room/FeaturedCategories/PressReleases/StatementonRecentStudiesRegardingCTScans.aspx. Accessed March 5 2013.

10.1288/00005537-197701000-00004

10.1212/WNL.0b013e318275978c

10.1056/NEJMoa072006

Katzung BG, Basic & Clinical Pharmacology

Sweetman SC, 2004, Martindale: The Complete Drug Reference

10.1016/j.ijporl.2012.02.044

Atzema C, 2006, Should we use steroids to treat children with Bell's palsy?, Can Fam Physician, 52, 313

10.1177/0194599811415823a364

10.1177/088307380101600805

10.1097/01.mlg.0000248737.65607.9e

10.1345/aph.1H077

Allen D, 2004, Aciclovir or valaciclovir for Bell's palsy (idiopathic facial paralysis), Cochrane Database Syst Rev, CD001869

10.1111/j.1749-4486.2010.02084.x

10.1001/jama.2009.1243

10.1136/emj.19.4.326

10.1111/j.1749-4486.2012.02526.x

10.1136/bmj.b3354

10.1001/archoto.2009.44

10.1186/1471-2377-11-1

10.1097/01.mao.0000265190.29969.12

Shahidullah M, 2011, Comparative study between combination of famciclovir and prednisolone with prednisolone alone in acute Bell's palsy, Mymensingh Med J, 20, 605

10.1007/s11910-010-0143-1

10.1097/CCM.0b013e31818f0ee7

10.1136/bjo.60.2.97

10.1007/s00417-005-0122-4

10.1017/S1481803500009398

Flynn CA, 1998, Should we patch corneal abrasions? A meta‐analysis, J Fam Pract, 47, 264

2010, What to do about Bell's palsy: recovery takes time, patience, proper eye care, and maybe a medication, Harv Womens Health Watch, 17, 5

10.1177/112067210901900218

10.1097/PEC.0b013e3181f3bd4a

Mitchell J, 2004, Tintinalli's Emergency Medicine: A Comprehensive Study Guide

10.4103/0972-2327.83092

Rodrigues de, 2008, Management of Bell's palsy: a report of 2 cases, J Can Dent Assoc, 74, 823

College of Optometrists.Facial palsy (including Bell's palsy). In:Clinical Management Guidelines.2008.http://www.college‐optometrists.org/en/utilities/document‐summary.cfm/docid/63AD5CC8‐EB0F‐41CB‐89508DC2D43560FB. Accessed February 13 2013.

Turner A, 2006, Patching for corneal abrasion, Cochrane Database Syst Rev, CD004764

10.1097/00002341-199312000-00003

10.1080/01676830490916082

10.1288/00005537-198009000-00017

10.1097/MAO.0b013e31823556ae

Sinha PK, 1994, Predictability of recovery from Bell's palsy using evoked electromyography, Am J Otol, 15, 769

10.1097/MAO.0b013e31821da2c6

Gilliatt RW, 1959, Electrical changes following section of the facial nerve, Proc R Soc Med, 53, 1080

10.3109/00016489409128320

10.1177/019459989210700306

10.1212/WNL.56.7.830

McAllister K, 2011, Surgical interventions for the early management of Bell's palsy, Cochrane Database Syst Rev, CD007468

10.1001/archotol.1972.00770080529008

10.1016/S0196-0709(82)80066-5

10.3109/00016487509124702

10.1177/00034894810900S401

Adour KK, 1971, Facial paralysis in 403 consecutive patients: emphasis on treatment response in patients with Bell's palsy, Trans Am Acad Ophthalmol Otolaryngol, 75, 1284

May M, 1984, Indications for surgery for Bell's palsy, Am J Otol, 5, 503

Aoyagi M, 1988, Results of facial nerve decompression, Acta Otolaryngol Suppl, 446, 101

10.1067/mhn.2001.112309

10.3349/ymj.2007.48.6.963

10.1017/S0022215109991265

10.1016/S0030-6665(20)30991-9

Brackmann DE, 1994, Technical modifications to the middle fossa craniotomy approach in removal of acoustic neuromas, Am J Otol, 15, 614

10.1288/00005537-198707000-00001

10.1288/00005537-198904000-00009

10.1002/lary.21906

10.1016/j.jpedsurg.2011.06.036

Chen N, 2010, Acupuncture for Bell's palsy, Cochrane Database Syst Rev, CD002914

10.1136/aim.2009.000455

10.1142/S0192415X09006631

10.1007/s11655-011-0861-5

10.1016/S0197-2456(97)00150-5

10.1016/j.ijsu.2012.04.019

10.2471/BLT.10.076737

Endres HG, 2004, An internal standard for verifying the accuracy of serious adverse event reporting: the example of an acupuncture study of 190,924 patients, Eur J Med Res, 9, 545

10.1159/000209315

10.1089/acm.1996.2.291

10.1136/bmj.323.7311.485

10.1136/qshc.2003.009134

10.1089/acm.2009.0181

10.1054/ctim.2001.0446

10.1089/acm.2011.0825

10.1136/aim.22.3.122

10.1177/0269215510395634

Teixeira LJ, 2011, Physical therapy for Bell's palsy (idiopathic facial paralysis), Cochrane Database Syst Rev, CD006283

10.1097/00129492-200307000-00024

10.1016/j.amjoto.2004.04.010

10.1016/S0004-9514(06)70026-5

10.1097/01.mao.0000217350.09796.07

10.1097/MAO.0b013e31816c7bf1

10.3109/00016480902882469

10.1177/0269215507070790

10.1016/S0194-59980223254-4

10.1097/00129492-200411000-00026